76,000% gain. Teeka Tiwari’s latest pitch.Reveals Tech Industry Set to Surge 76,000%
This is the hook He is using right now. ” Wall Street Exec shocks audience” etc. Any ideas?.
Stephen Shaw.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Yes, EHP has removed the $3000 minimum.
No they haven’t, it says minimum 3000 when you hit next.
Ouch. My bad, I didn’t go beyond the first screen. Gettin’ greedy, are they?
Be aware:
EMERALD HEALTH PHARMACEUTICALS SUBSCRIPTION AGREEMENT PROCESS
“When shares are purchased at an early stage in a private company, it is usual that if the company becomes publicly listed on a stock exchange the shares would be locked up for some period of time. In the case of Emerald Health Pharmaceuticals, the potential lock-up would be 180 days from the day the shares are registered, which would roughly occur in conjunction with a public listing. When you sign your subscription agreement, you are also agreeing to this requirement“
-EPH has been raising funds since 2017.
-In 2018 shares were $5 each
-They have raised $20m so far
– They aim to raise $50m
Hmmm… Teeka indicated that it was a 75 cent stock. Emerald doesn’t appear to have been a 75 cent stock at any point in time. Could we be wrong about it?
Yes, that was for his previous pre-IPO pick ‘Flora Growth’.
I looked at Flora Growth. Still the same price, except they are throwing in 1/2 a warrant with each unit purchased. Looks like a great business model as well. Woo Hoo! Going to get me some of that!
I also am considering whether to invest more into Flora or put some into EHP.
This is supposed to be his first ever biotech recommendation
EPH is interesting. The $3k and the 180 day lock up dont scare me. What bothers me more is the performance (or lack of) of 2 other Emerald compainies since IPO. EMHTF, EMBI. I know you can’t necessarily judge EPH against these but….. it is the same family…
Long time reader, first time “commenter” (sic). I think we can all agree Teeka is plugging Emerald Health Pharmaceuticals https://emeraldpharma.life/pipeline/ …but does anyone have a strong opinion as to whether getting it at $6 share pre-IPO is still wise?
If it weren’t for the FDA approval I’d give this one a miss because of the lock up period, the share price increase and the human trials won’t be ready for at least another year. The orphan drug status thing is apparently a big deal but can equally be revoked easily.
EPH is interesting. The $3k and the 180 day lock up dont scare me. What bothers me more is the performance (or lack of) of 2 other Emerald compainies since IPO. EMHTF, EMBI. I know you can’t necessarily judge EPH against these but….. it is the same family…